AbbVie: Strategy Presentations (AbbVie) - Oct 31, 2015 - Anticipated initiation of P2 trial for psoriasis in Q4 2015-2016; Anticipated initiation of P3 trial for rheumatoid arthritis in Q4 2015-2016
Anticipated new P2 trial • Anticipated new P3 trial • Psoriasis • Rheumatoid Arthritis
|